• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NEO

NEO

NeoGenomics, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD10.14

+0.02 (+0.20%)

Rating:C

Company Profile

CEO

Anthony Zook

IPO Date

2004-03-16

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.08

Prev. Close

$10.12

Day Low

$9.89

Day High

$10.37

52W Low

$4.72

52W High

$13.74

Market Cap

$0.26B

Volume

1.25M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

32.3%

Avg Negative

22.5%

Avg Neutral

45.3%

News Feed

Bear of the Day: NeoGenomics (NEO)

Zacks Investment Research·7/30/2021·↓ negative

NeoGenomics: Strong Growth Potential For A Leader In Cancer Diagnostic Testing

Seeking Alpha·7/2/2021·↓ negative

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Accesswire·6/18/2021·↑ positive

Moving Average Crossover Alert: NeoGenomics (NEO)

Zacks Investment Research·6/8/2021·↓ negative

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

Accesswire·5/27/2021·↑ positive

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

Accesswire·5/10/2021·↑ positive

NeoGenomics (NEO) CEO Mark Mallon on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

Accesswire·5/5/2021·↑ positive

NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Accesswire·5/5/2021·↑ positive

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients

Accesswire·4/19/2021·↑ positive